Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY-NC-ND 4.0JACC: Advances

GLP-1 Receptor Agonist Use and Long-Term Outcomes in Hypertrophic Cardiomyopathy With Obstructive Sleep Apnea

  1. 1Hypertrophic Cardiomyopathy Center, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA
  2. 2The Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio, USA

Related

  1. Real-World Implementation and Clinical Outcomes of Mavacamten in an Underserved Urban Cohort With Obstructive Hypertrophic Cardiomyopathy
    J. Bock, S. Murthy, A. L. Schenone +1
    medRxivPreprintCC BY-NC-NDFull textCardiovascular medicinemedRxiv
  2. Liwen Ablation versus Modified Morrow Myectomy for Obstructive Hypertrophic Cardiomyopathy: 1-Year Hemodynamic and Conduction Outcomes
    J. Jiao, Y. Long, Z. Yu +3
    medRxivPreprintCC BY-NC-NDFull textCardiovascular medicinemedRxiv
  3. Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report
    Smita Scholtz, Felix Langkamp, Volker Rudolph +2
    Journal of cardiology casesPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Percutaneous endomyocardial ablation as a septal reduction strategy in symptomatic obstructive hypertrophic cardiomyopathy: A 20-year single-center observational experience.
    Aoife Casey, John McCormick, David Keane
    HeartRhythm case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Hypertrophic obstructive cardiomyopathy complicated by severe midventricular obstruction treated with percutaneous transluminal septal myocardial ablation using simultaneous contrast imaging with left ventriculography and coronary angiography: a case report
    European heart journal. Case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
BibTeX
@article{shah2026glp1,
  title = {{GLP-1 Receptor Agonist Use and Long-Term Outcomes in Hypertrophic Cardiomyopathy With Obstructive Sleep Apnea}},
  author = {Stuti Shah and Mohammed Abusafia and Hesham Sheashaa and Shada Jadam and Susan Ospina and David Kaelber and Susan K. Keen and Milind Y. Desai},
  journal = {JACC: Advances},
  year = {2026},
  month = aug,
  doi = {10.1016/j.jacadv.2026.102955},
  url = {https://doi.org/10.1016/j.jacadv.2026.102955},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - GLP-1 Receptor Agonist Use and Long-Term Outcomes in Hypertrophic Cardiomyopathy With Obstructive Sleep Apnea
AU  - Stuti Shah
AU  - Mohammed Abusafia
AU  - Hesham Sheashaa
AU  - Shada Jadam
AU  - Susan Ospina
AU  - David Kaelber
AU  - Susan K. Keen
AU  - Milind Y. Desai
PY  - 2026
DA  - 2026/08/28
JO  - JACC: Advances
DO  - 10.1016/j.jacadv.2026.102955
UR  - https://doi.org/10.1016/j.jacadv.2026.102955
SN  - 2772-963X
ER  -